The Discounted Cash Flow (DCF) valuation of Willow Biosciences Inc (WLLW.TO) is (6,481.07) CAD. With the latest stock price at 0.25 CAD, the upside of Willow Biosciences Inc based on DCF is -2592527.2%.
Based on the latest price of 0.25 CAD and our DCF valuation, Willow Biosciences Inc (WLLW.TO) is a sell. selling WLLW.TO stocks now will result in a potential gain of 2592527.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 8.2% - 10.2% | 9.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (10,543.44) - (4,691.31) | (6,481.07) |
| Upside | -4217476.6% - -1876625.2% | -2592527.2% |